JP2003527072A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003527072A5 JP2003527072A5 JP2000577277A JP2000577277A JP2003527072A5 JP 2003527072 A5 JP2003527072 A5 JP 2003527072A5 JP 2000577277 A JP2000577277 A JP 2000577277A JP 2000577277 A JP2000577277 A JP 2000577277A JP 2003527072 A5 JP2003527072 A5 JP 2003527072A5
- Authority
- JP
- Japan
- Prior art keywords
- library
- primary
- mutants
- sequences
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000035772 mutation Effects 0.000 description 5
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 4
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 4
- 101710204410 Scaffold protein Proteins 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10461298P | 1998-10-16 | 1998-10-16 | |
| US60/104,612 | 1998-10-16 | ||
| US15870099P | 1999-10-08 | 1999-10-08 | |
| US60/158,700 | 1999-10-08 | ||
| PCT/US1999/024229 WO2000023564A2 (en) | 1998-10-16 | 1999-10-15 | Protein design automation for protein libraries |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003527072A JP2003527072A (ja) | 2003-09-16 |
| JP2003527072A5 true JP2003527072A5 (https=) | 2006-06-29 |
Family
ID=26801737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000577277A Pending JP2003527072A (ja) | 1998-10-16 | 1999-10-15 | 蛋白質ライブラリーに関する蛋白質設計オートメーション |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1157093A1 (https=) |
| JP (1) | JP2003527072A (https=) |
| AU (2) | AU774334B2 (https=) |
| CA (1) | CA2347214A1 (https=) |
| WO (1) | WO2000023564A2 (https=) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0974111T3 (da) | 1997-04-11 | 2003-04-22 | California Inst Of Techn | Apparat og metode til automatiseret design af proteiner |
| US7315786B2 (en) | 1998-10-16 | 2008-01-01 | Xencor | Protein design automation for protein libraries |
| US20020048772A1 (en) | 2000-02-10 | 2002-04-25 | Dahiyat Bassil I. | Protein design automation for protein libraries |
| US6917882B2 (en) | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| US20070065838A1 (en) | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| ES2341217T3 (es) | 1999-01-19 | 2010-06-17 | Maxygen, Inc. | Recombinacion de acidos nucleicos mediada por oligonucleotidos. |
| US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
| US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
| US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
| US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
| US6946265B1 (en) | 1999-05-12 | 2005-09-20 | Xencor, Inc. | Nucleic acids and proteins with growth hormone activity |
| US6746853B1 (en) | 1999-05-19 | 2004-06-08 | Xencor, Inc. | Proteins with insulin-like activity useful in the treatment of diabetes |
| US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| IL150291A0 (en) | 2000-01-11 | 2002-12-01 | Maxygen Inc | Integrated systems and methods for diversity generation and screening |
| EP1621617A1 (en) * | 2000-02-10 | 2006-02-01 | Xencor, Inc. | Protein design automation for protein libraries |
| EP1255826B1 (en) * | 2000-02-10 | 2005-09-14 | Xencor | Protein design automation for protein libraries |
| US7244823B2 (en) | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
| US7687461B2 (en) | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
| US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
| US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
| US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
| US7662367B2 (en) | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
| AU2001278872A1 (en) * | 2000-07-06 | 2002-01-21 | Genvec, Inc. | Method of identifying a binding partner of a gene product |
| DE50015173D1 (de) | 2000-07-13 | 2008-07-03 | Ct Concept Technologie Ag | Verfahren und vorrichtung zur zustandsabhängigen regelung des transienten verhaltens von leistungshalbleiterschaltern |
| AU2002211624A1 (en) * | 2000-10-10 | 2002-04-22 | Genencor International, Inc. | Information rich libraries |
| US7351690B2 (en) | 2000-12-19 | 2008-04-01 | Palatin Technologies, Inc. | Knockout identification of target-specific sites in peptides |
| WO2002068453A2 (en) * | 2001-02-22 | 2002-09-06 | Xencor | Methods and compositions for the construction and use of fusion libraries using computational protein design methods |
| JP2005505250A (ja) | 2001-05-04 | 2005-02-24 | ゼンコー | 核酸およびチオレドキシンレダクターゼ活性を有するタンパク質 |
| US7381792B2 (en) | 2002-01-04 | 2008-06-03 | Xencor, Inc. | Variants of RANKL protein |
| US7662925B2 (en) | 2002-03-01 | 2010-02-16 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| US8188231B2 (en) | 2002-09-27 | 2012-05-29 | Xencor, Inc. | Optimized FC variants |
| US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
| US7317091B2 (en) | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
| DE10233047A1 (de) * | 2002-07-19 | 2004-02-26 | Amaxa Gmbh | Verfahren zur Herstellung eines künstlichen Polypeptids und nach diesem Verfahren hergestelltes künstliches Protein |
| US8388955B2 (en) | 2003-03-03 | 2013-03-05 | Xencor, Inc. | Fc variants |
| US20090010920A1 (en) | 2003-03-03 | 2009-01-08 | Xencor, Inc. | Fc Variants Having Decreased Affinity for FcyRIIb |
| US8084582B2 (en) | 2003-03-03 | 2011-12-27 | Xencor, Inc. | Optimized anti-CD20 monoclonal antibodies having Fc variants |
| US9051373B2 (en) | 2003-05-02 | 2015-06-09 | Xencor, Inc. | Optimized Fc variants |
| US9714282B2 (en) | 2003-09-26 | 2017-07-25 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| US8101720B2 (en) | 2004-10-21 | 2012-01-24 | Xencor, Inc. | Immunoglobulin insertions, deletions and substitutions |
| AU2004297616B2 (en) | 2003-12-04 | 2008-12-18 | Xencor, Inc. | Methods of generating variant proteins with increased host string content and compositions thereof |
| EP1737890A2 (en) | 2004-03-24 | 2007-01-03 | Xencor, Inc. | Immunoglobulin variants outside the fc region |
| US20150010550A1 (en) | 2004-07-15 | 2015-01-08 | Xencor, Inc. | OPTIMIZED Fc VARIANTS |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| AU2005304624B2 (en) | 2004-11-12 | 2010-10-07 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8802820B2 (en) | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| EP1836223B1 (en) * | 2005-01-03 | 2011-11-23 | F. Hoffmann-La Roche AG | Method for identifying a nucleic acid encoding a hemopexin-like structure which specifically binds a predetermined target molecule. |
| WO2007041635A2 (en) | 2005-10-03 | 2007-04-12 | Xencor, Inc. | Fc variants with optimized fc receptor binding properties |
| WO2007044616A2 (en) | 2005-10-06 | 2007-04-19 | Xencor, Inc. | Optimized anti-cd30 antibodies |
| PL2383297T3 (pl) | 2006-08-14 | 2013-06-28 | Xencor Inc | Zoptymalizowane przeciwciała ukierunkowane na CD19 |
| WO2008036688A2 (en) | 2006-09-18 | 2008-03-27 | Xencor, Inc. | Optimized antibodies that target hm1.24 |
| HRP20150279T1 (hr) | 2007-12-26 | 2015-05-08 | Xencor, Inc. | Fc inaäśice s promijenjenim vezanjem na fcrn |
| US12492253B1 (en) | 2008-02-25 | 2025-12-09 | Xencor, Inc. | Anti-human C5 antibodies |
| JP5703022B2 (ja) | 2008-09-26 | 2015-04-15 | 日本水産株式会社 | 脂質の製造方法 |
| WO2011028952A1 (en) | 2009-09-02 | 2011-03-10 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| WO2011091078A2 (en) | 2010-01-19 | 2011-07-28 | Xencor, Inc. | Antibody fc variants with enhanced complement activity |
| KR102902195B1 (ko) * | 2019-02-07 | 2025-12-18 | 바이오스트랜드 비브이 | 생물학적 정보 핸들링 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| GB9701425D0 (en) * | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
| DK0974111T3 (da) * | 1997-04-11 | 2003-04-22 | California Inst Of Techn | Apparat og metode til automatiseret design af proteiner |
| CA2373135A1 (en) * | 1999-05-12 | 2000-11-16 | Xencor, Inc. | Novel thermostable alkaliphilic xylanase |
-
1999
- 1999-10-15 AU AU11190/00A patent/AU774334B2/en not_active Ceased
- 1999-10-15 JP JP2000577277A patent/JP2003527072A/ja active Pending
- 1999-10-15 WO PCT/US1999/024229 patent/WO2000023564A2/en not_active Ceased
- 1999-10-15 CA CA002347214A patent/CA2347214A1/en not_active Abandoned
- 1999-10-15 EP EP99954972A patent/EP1157093A1/en not_active Withdrawn
-
2004
- 2004-07-16 AU AU2004203224A patent/AU2004203224B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003527072A5 (https=) | ||
| Médigue et al. | Evidence for horizontal gene transfer in Escherichia coli speciation | |
| Reynaud et al. | Somatic generation of diversity in a mammalian primary lymphoid organ: the sheep ileal Peyer's patches | |
| Segal et al. | Antigenic variation of gonococcal pilus involves assembly of separated silent gene segments. | |
| JP2002534966A5 (https=) | ||
| AU2002215346A1 (en) | Method for generating a library of oligonucleotides comprising a controlled distribution of mutations | |
| Boysen et al. | Analysis of the 1.1-Mb human α/δ T-cell receptor locus with bacterial artificial chromosome clones | |
| EP1108783A3 (en) | Oligonucleotide-mediated nucleic acid recombination | |
| JP2002531053A5 (https=) | ||
| HUE029938T2 (en) | Combined, automated parallel synthesis of polynucleotide variants | |
| WO2004031351A3 (en) | Microarrays having multiple oligonucleotides in single array features | |
| JP2003501069A5 (https=) | ||
| CA2945628A1 (en) | Long nuceic acid sequences containing variable regions | |
| EP0800526B1 (en) | Method for the controlled synthesis of polynucleotide mixtures which encode desired mixtures of peptides | |
| WO2002097096A3 (en) | Nucleotide sequences which code for the metd gene | |
| CN105925671A (zh) | 一种从核酸样品富集目标序列核酸的方法 | |
| Nishigaki et al. | Random PCR-based genome sequencing: a non-divide-and-conquer strategy | |
| Xu et al. | Gene hunting without sequencing genomic clones: finding exon boundaries in cDNAs | |
| MY114645A (en) | Cytochrome bd type quinol oxidase gene of brevibacterium lactofermentum | |
| Haegeman et al. | Studies on the bacteriophage MS2: IX. The heptanucleotide sequences present in the pancreatic ribonuclease digest of the viral RNA | |
| WO2003027296A1 (en) | GENES PARTICIPATING IN THE SYNTHESIS OF FATTY ACID HAVING trans-11-, cis-13- CONDJUGATED DOUBLE BOND AND UTILIZATION THEREOF | |
| US8470537B2 (en) | Sequential addition of short DNA oligos in DNA-polymerase-based synthesis reactions | |
| Kasai et al. | Efficient large-scale sequencing of the Escherichia coli genome: Implementation of a transposon-and PCR-based strategy for the analysis of ordered λ phage clones | |
| WO1997047639A1 (en) | Photocleavable cyclic oligonucleotide | |
| WO2003093461A3 (fr) | Banque genomique du cyanophage s-2l et analyse fonctionnelle |